Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

NYSTATIN 500,000 UNIT ORAL TAB

nystatin
$0.3521per EA

Strength

500000 [USP'U]/1

Manufacturer

Heritage Pharmaceuticals Inc.

NDC

23155005101

Classification

Generic

Dosage Form

TABLET, COATED

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

NYSTATIN

Approval Type

Generic (ANDA)

FDA Application

ANDA062474

On Market Since

10/31/2011

Pharmacological Classes

Polyene Antifungal
Polyenes

Price History

1W

0.0%

1M

-0.5%

3M

-10.2%

6M

-9.8%

1Y

+1.0%

3Y

-0.7%

5Y

-12.4%

All

-22.4%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

NYSTATIN 100,000 UNIT/ML SUSP
Generic
00121081016•Pharmaceutical Associates, Inc.
$0.0561
per ML
NYSTATIN 100,000 UNIT/ML SUSP
Generic
00121086816•PAI Holdings LLC
$0.0623
per ML
NYSTATIN 100,000 UNIT/ML SUSP
Generic
00121104516•PAI Holdings LLC
$0.0623
per ML
NYSTATIN 100,000 UNIT/ML SUSP
Generic
62135081347•Chartwell RX LLC
$0.0623
per ML
NYSTATIN 100,000 UNIT/ML SUSP
Generic
69315050447•Leading Pharma, LLC
$0.0623
per ML
NYSTATIN 100,000 UNIT/ML SUSP
Generic
51672411709•Taro Pharmaceuticals U.S.A. Inc.
$0.0761
per ML
NYSTATIN 100,000 UNIT/ML SUSP
Generic
00121081002•Pharmaceutical Associates, Inc.
$0.1264
per ML
NYSTATIN 100,000 UNIT/ML SUSP
Generic
51672411704•Taro Pharmaceuticals U.S.A. Inc.
$0.1426
per ML
NYSTATIN 100,000 UNIT/ML SUSP
Generic
00121086802•PAI Holdings LLC
$0.1458
per ML
NYSTATIN 100,000 UNIT/ML SUSP
Generic
62135081346•Chartwell RX LLC
$0.1458
per ML

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy